iBio Inc Stock, ASE:IBIO
600 Madison Avenue, Suite 1601, New York, New York 10022
United States of America
Number of Employees: 75
iBio, Inc. is a biotechnology company, which engages in the development and manufacture of biotherapeutics. Its pipeline include idiopathic pulmonary fibrosis, systemic sclerosis, and scleroderma. The firm operates through the Biopharmaceuticals and Bioprocessing segments. The company was founded by Robert B. Kay on April 15, 1993 and is headquartered in Bryan, TX.